Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-024530
Date:2021-06-15
Issuer: AILERON THERAPEUTICS INC (ALRN)
Original Submission Date:

Reporting Person:

AMBROS REINHARD J.
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101 BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.29 2021-06-15 deemed execution date A 96,000 (a) 2031-06-14 common stock 96,000 $1.29 96,000 direct
Footnotes
IDfootnote
f1 this option was granted on june 15, 2021. the shares underlying the option are scheduled to vest in full on the earlier of (i) june 15, 2022 or (ii) the date of the issuer's 2022 annual meeting of stockholders.
WhaleWisdom Logo

Elevate your investments